1 citations
,
September 2023 in “Dermatology and therapy” This review explores the efficacy and safety of treatments for dissecting cellulitis of the scalp, revealing a predominance of case reports and series, and concludes that randomized controlled trials are needed for better evidence-based therapies.
48 citations
,
January 2014 in “Dermatology Online Journal” This review examines various treatments for dissecting cellulitis, noting isotretinoin may offer the best chance for remission despite limited long-term data and calls for more clinical studies.
July 2026 in “The scientific and practical journal Dermatology and infectious diseases” In this review study, systemic isotretinoin emerged as the most effective treatment for dissecting cellulitis of the scalp, while biologics and JAK inhibitors showed promise for resistant cases, and procedural methods were used in severe stages; however, controlled studies are needed for developing clinical guidelines.
July 2018 in “Elsevier eBooks” This study underscores the importance of using trichoscopy and histopathology for the differential diagnosis of primary neutrophilic cicatricial alopecias to facilitate early intervention and prevent cicatricial alopecia progression.
April 2026 in “Dermatology and Therapy” This study reviews the efficacy and safety of advanced therapies like TNFα inhibitors and IL-17/IL-23 inhibitors for dissecting cellulitis of the scalp, finding TNFα inhibitors particularly effective for severe or refractory cases, although prospective validation is needed for early intervention benefits.